CORCEPT THERAPEUTICS Chart calendar Corcept Therapeutics
7a797b79cffe535ad60b02fecc32e7.PXIBHI5NjxWa_-q_A7l4TTxfu7mgSz_QYmTg-qXPKUU.BBEyW9sUx3TWvoSMc_UQGHIm3ezDfU6fAyGHlN2-SysORXgr_ya3XfXNnQ~a132a9fd2ff9608cd44cfa755d7106ce
Upcoming events on Corcept Therapeutics
Past events on Corcept Therapeutics
| 02/05/2024 02:30 am | Q1 2024 Earnings Call |
| 02/05/2024 01:35 am | Q1 2024 Earnings Release |
| 16/02/2024 03:30 am | Q4 2023 Earnings Call |
| 16/02/2024 02:35 am | Q4 2023 Earnings Release |
| 02/11/2023 02:30 am | Q3 2023 Earnings Call |
| 02/11/2023 01:35 am | Q3 2023 Earnings Release |
| 03/08/2023 02:30 am | Q2 2023 Earnings Call |
| 03/08/2023 01:35 am | Q2 2023 Earnings Release |
| 19/05/2023 08:00 pm | Annual General Meeting |
| 04/05/2023 02:30 am | Q1 2023 Earnings Call |
| 04/05/2023 01:35 am | Q1 2023 Earnings Release |
| 16/03/2023 | Jefferies Biotech on the Bay Summit |
| 01/03/2023 03:30 am | Q4 2022 Earnings Call |
| 01/03/2023 02:35 am | Q4 2022 Earnings Release |
| 17/02/2023 01:30 am | SVB Securities Global Biopharma Conference |
| 04/11/2022 02:30 am | Q3 2022 Earnings Call |
| 04/11/2022 01:35 am | Q3 2022 Earnings Release |
| 04/08/2022 02:30 am | Interim 2022 Earnings Call |
| 04/08/2022 01:35 am | Interim 2022 Earnings Release |
| 06/06/2022 07:30 pm | American Society of Clinical Oncology Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 307 306 0.02% | 354 358 -1.28% | 366 368 -0.47% | 402 404 -0.5% | 482 476 1.28% | 632 |
|
EBITDA Million USD | Released Forecast Spread | 112 116 -3.02% | 129 125 3.07% | 126 149 -15.93% | 156 160 -2.53% | 0,00 102 - | 137 |
|
EBIT Million USD | Released Forecast Spread | 112 113 -1.51% | 128 123 4.55% | 124 131 -5.31% | 113 140 -19.59% | 107 109 -1.52% | 122 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 117 118 -1.24% | 132 127 3.29% | 125 126 -0.53% | 116 127 -8.79% | 125 124 0.58% | 134 |
|
Net income Million USD | Released Forecast Spread | 94,2 96,8 -2.67% | 106 101 4.74% | 113 110 2.53% | 101 114 -11.14% | 105 104 1.27% | 109 |
|
EPS USD | Released Forecast Spread | 0,77 0,78 -1.28% | 0,85 0,81 5.59% | 0,89 0,86 3.29% | 0,87 0,96 -8.9% | 0,94 0,92 1.95% | 0,96 |
| Announcement Date | 20/02/20 | 08/02/21 | 15/02/22 | 28/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 93,7 98,6 -4.98% | 103 101 2.36% | 102 108 -5.43% | 103 105 -1.93% | 106 105 0.71% | 118 110 7.4% | 124 120 3.24% | 135 129 4.72% | 147 141 3.97% | 155 | 162 | 168 | 167 | 173 |
|
EBITDA Million USD | Released Forecast Spread | 37,8 45,0 -15.96% | 42,2 43,8 -3.76% | 42,7 42,5 0.43% | 33,2 37,2 -10.74% | 26,2 24,0 9.03% | 29,8 19,3 54.24% | ||||||||
|
EBIT Million USD | Released Forecast Spread | 26,8 36,6 -26.84% | 31,4 35,7 -11.93% | 31,9 36,7 -12.91% | 22,5 37,2 -39.47% | 14,9 25,5 -41.71% | 29,6 18,2 62.43% | 31,2 26,9 15.77% | 31,7 33,3 -4.94% | 29,5 27,8 6.03% | 29,1 | 31,0 | 33,9 | 34,0 | 37,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 26,8 35,7 -24.82% | 32,1 32,4 -1.19% | 33,0 33,4 -1.18% | 24,3 35,5 -31.58% | 18,4 24,9 -25.97% | 32,9 19,7 66.88% | 36,4 28,7 26.6% | 36,8 36,1 1.97% | 35,0 30,6 14.32% | 31,7 | 33,5 | 35,8 | 37,3 | 41,2 |
|
Net income Million USD | Released Forecast Spread | 22,8 28,3 -19.54% | 27,4 26,1 4.95% | 34,6 27,8 24.33% | 16,6 29,2 -43.27% | 15,8 21,1 -25.23% | 27,4 17,2 59.26% | 31,2 24,4 27.88% | 31,1 29,6 5.25% | 27,5 25,3 8.97% | 26,2 | 27,7 | 29,8 | 29,6 | 32,7 |
|
EPS USD | Released Forecast Spread | 0,20 0,23 -13.79% | 0,24 0,21 12.15% | 0,30 0,23 30.43% | 0,14 0,23 -37.78% | 0,14 0,19 -27.58% | 0,25 0,15 66.67% | 0,28 0,22 28.25% | 0,28 0,26 8.53% | 0,25 0,22 13.64% | 0,23 | 0,24 | 0,26 | 0,28 | 0,31 |
| Announcement Date | 05/05/22 | 03/08/22 | 03/11/22 | 28/02/23 | 03/05/23 | 02/08/23 | 01/11/23 | 15/02/24 | 01/05/24 | - | - | - | - | - |
| Today 04:00 pm | PERRIGO COMPANY PLC: Q1 2024 Earnings Release |
| Today 01:30 am | OCULAR THERAPEUTIX, INC.: Q1 2024 Earnings Release |
| Today 01:31 am | LIGAND PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
| Today 01:35 am | SIGA TECHNOLOGIES, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | IMMUNOCORE HOLDINGS PLC: Q1 2024 Earnings Release (Projected) |
| 08/05/2024 | AMPHASTAR PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | TARSUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | AVADEL PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 08/05/2024 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q1 2024 Earnings Release (Projected) |
| 08/05/2024 | CAMURUS AB: Q1 2024 Earnings Release |